Metabolic Solutions Development Co.

metabolic solutions

Kalamazoo Firm Presents Clinical Trial Results Of Alzheimer’s Drug

Metabolic Solutions Development Co. LLC announced that Jerry Colca, co-founder and chief scientific officer of MSDC, presented results of a Phase 2a study at the 14th International Conference on Alzheimer’s Drug Discovery.

WWJ Newsradio 950–09/09/2013

Kalamazoo Company Announces New Drug Target For Diabetes

Metabolic Solutions Development Co. LLC announced Wednesday the publication of data in the latest issue of the scientific journal PLOS ONE on a new drug target for treating type 2 diabetes by boosting the body’s sensitivity to insulin.

WWJ Newsradio 950–05/15/2013

The Southwest Michigan Innovation Center, run by Southwest Michigan First.

Officials: Diabetes Breakthrough Shows Value Of Life Science Incubators

Breakthrough research by Metabolic Solutions Development Co., including data published Wednesday on a new drug target for type 2 diabetes, underscores the key role a quality life sciences incubator can play, according to southwest Michigan life science leaders.

WWJ Newsradio 950–05/15/2013

metabolic solutions

New Treatment Possible For Type 2 Diabetes

A study published online in the Journal of Biological Chemistry showed a new drug to treat diabetes being developed by Metabolic Solutions Development Co. LLC, MSDC-0602, improved insulin resistance and inflammation in obese mice.

WWJ Newsradio 950–05/29/2012

metabolic solutions

Kalamazoo Pharma Startup To Present At Diabetes Conference

Kalamazoo-based Metabolic Solutions Development Co. and collaborators will present their research providing insights into the therapeutic potential of increasing brown adipose (fat) tissue in the treatment of diabetes and the unique mechanism of action of the […]

WWJ Newsradio 950–06/21/2011

metabolic solutions

Metabolic Solutions Launches New Trial Of Diabetes Drug

Kalamazoo-based Metabolic Solutions Development Co., a drug discovery and development company exploiting novel molecular targets to treat metabolic diseases, announced Tuesday that it has launched a Phase 2a trial for MSDC-0602, the company’s second drug candidate for the treatment of type 2 diabetes.


Kalamazoo Pharma Firm To Present Advance In Obesity Treatment

A Kalamazoo pharma startup has a drug candidate that may offer better treatment for diseases related to obesity, including diabetes. Metabolic Solutions Development Co. will present research at the European Association for the Study of […]